LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathwayMing Zhang, Lin Zhao|Journal of Experimental & Clinical Cancer Research|2021Cited by 50